Skip to search formSkip to main contentSkip to account menu

Myelodysplastic Syndrome, Unclassifiable

Known as: MDS-U, Unclassifiable MDS, Unclassifiable Myelodysplastic Syndrome 
A subtype of myelodysplastic syndrome which initially lacks findings appropriate for classification into any other myelodysplastic category. There… 
National Institutes of Health

Related topics

Related topics

11 relations
AgranulocytosisBone MarrowBone marrow stem cellHematopoietic and Lymphoid Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Nové možnosti v léčbě myelodysplastického syndromu
Myelodysplastický syndrom (MDS) je heterogenni skupina klonalnich onemocněni krvetvorne kmenove buňky, ktera se vyznacuje… 
2013
2013
Prognostic Factors Of Response and Survival To Azacitidine (AZA) +/- EPO In RBC Transfusion Dependent (TD) IPSS Low and Int-1 (LR) MDS Resistant To EPO, With Particular Emphasis Of Genetic Lesions: A…
Background Although anemia of LR MDS initially responds to erythroid stimulating agents (ESA) in 40-50% of patients, response is… 
2011
2011
Type-A Nucleophosmin (Npm1) Gene Mutation as a Prognostic Marker in Myelodysplastic Syndrome Patients with Normal Karyotypes
Background: MDS are stem cell disorders characterized by impaired hematopoiesis, and variable risk of AML. MDS can be primary or… 
Review
2010
Review
2010
Recherche de nouvelles cibles moléculaires dans les syndromes myélodysplasiques et leucémies aiguës myéloïdes
Background: Gene mutation is an important mechanism of myeloid leukemogenesis. However, the number and combination of gene… 
2004
2004
Isolated interstitial 9q deletion in a case of unclassifiable myelodysplastic syndrome.